Epigenetic Consequences of in Utero Exposure to Rosuvastatin: Alteration of Histone Methylation Patterns in Newborn Rat Brains

Rosuvastatin (RST) is primarily used to treat high cholesterol levels. As it has potentially harmful but not well-documented effects on embryos, RST is contraindicated during pregnancy. To demonstrate whether RST could induce molecular epigenetic events in the brains of newborn rats, pregnant mother...

Descripción completa

Detalles Bibliográficos
Autores principales: Dulka, Karolina, Szabo, Melinda, Lajkó, Noémi, Belecz, István, Hoyk, Zsófia, Gulya, Karoly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059142/
https://www.ncbi.nlm.nih.gov/pubmed/33810299
http://dx.doi.org/10.3390/ijms22073412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059142/
https://www.ncbi.nlm.nih.gov/pubmed/33810299
http://dx.doi.org/10.3390/ijms22073412

Ejemplares similares